e Ehrlichia chaffeensis, the etiologic agent of human monocytic ehrlichiosis (HME), has been extensively studied as a cause of acute febrile illness and an emerging tick-borne zoonosis in the United States. Limited data suggest its presence in other regions, including Central and South America but not Nicaragua to date. Diagnosis of E. chaffeensis infection by indirect immunofluorescence assay (IFA) is the reference standard due to its presumed high sensitivity and specificity, but IFA is impractical, variably reproducible, and cumbersome for large epidemiologic studies and for clinical diagnosis in resource-poor regions. We evaluated a high-throughput, objective peptide-based enzyme-linked immunosorbent assay (ELISA) for use alone or in combination with IFA. We found that it performed best as a screening test (sensitivity, 100%; specificity, 84%) to reduce the proportion of serum samples that were required by the more cumbersome and subjective IFA testing to <20%. Using a two-step diagnostic approach (IFA is performed if the ELISA is positive), we identified E. chaffeensis or a serologically and antigenically similar organism as a heretofore unrecognized cause of acute febrile illness in humans in Nicaragua and demonstrated the utility of the peptide ELISA as a screening tool for large-scale clinical studies.
Rickettsiae are frequently the cause of acute febrile illness (AFI) in the tropics when rigorously sought; however, they are infrequently identified because of limited diagnostic tools to identify and confirm infections (1, 2). Ehrlichia chaffeensis, the etiologic agent of human monocytic ehrlichiosis (HME), has been extensively studied as a cause of acute febrile illness and an emerging tick-borne zoonosis in the United States (3). Limited data suggest its presence in other regions, including Central and South America but not Nicaragua to date (4). Serologic diagnosis of E. chaffeensis infection by indirect immunofluorescence assay (IFA) is the reference standard due to its presumed high sensitivity and specificity (5, 6). However, the technique is too time-consuming to be practical for large epidemiologic studies, requires the use of a fluorescence microscope, and requires highly experienced operators for reproducibility. Hence, clinical diagnosis and epidemiologic studies of Ehrlichia chaffeensis are not readily done in resource-poor regions. A peptide-based enzyme-linked immunosorbent assay (ELISA) has promise as a high-throughput, objective, and inexpensive diagnostic tool (7). We refined and optimized a peptide-based ELISA for E. chaffeensis infection and applied it to ascertain whether E. chaffeensis is an unrecognized cause of acute febrile illness in humans in Nicaragua.
MATERIALS AND METHODSEhrlichia chaffeensis peptide ELISA cutoff optimization. Convalescentphase serum samples from patients with PCR-, culture-, and/or blood smear-proven infections with E. chaffeensis (n ϭ 16; E. chaffeensis geometric mean titer [GMT] by IFA of 1,503 [range, 256 to 16,384] and Anaplasma phagocytophilum GMT by I...